Lenvatinib/Pembro Combo for Advanced Anaplastic Thyroid Cancer
The nonchemotherapy combination has shown durable responses in patients with metastatic anaplastic thyroid cancer that has progressed on chemotherapy.
Source: medscape.com
Stay updated with breaking news from Endocrinology Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The nonchemotherapy combination has shown durable responses in patients with metastatic anaplastic thyroid cancer that has progressed on chemotherapy.